Stephen R. Brady

Chief Business Officer, IMMUNE DESIGN CORP.

Companies

Tempest Therapeutics, Inc.Board member Jun 29, 2021 to now¹
Tempest Therapeutics, Inc.President Oct 13, 2023 to Feb 6, 2026²
Tempest Therapeutics, Inc.Chief executive officer Jun 29, 2021 to Feb 6, 2026¹
Atreca, Inc.Board member Jul 16, 2021 to Jun 15, 2023³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Tempest Therapeutics, Inc. TPST46,376 shares⁴$29.3K at $0.63Jul 3, 2024

As of each latest filing. The line shows shares held over time.

Recent filings

Jul 3, 2024Bought 35,000 shares at $2.11 of Tempest Therapeutics, Inc.⁴

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARTempest Therapeutics, Inc., Board member
2
SEC EDGARTempest Therapeutics, Inc., President
3
SEC EDGARAtreca, Inc., Board member
4
SEC EDGARTempest Therapeutics, Inc. shares after the filing of Jul 3, 2024